Pharma oncology, also known as pharmaceutical oncology, is the branch of pharmaceutical science that focuses on the development, production, and distribution of drugs used in the treatment of cancer. It involves researching and developing new drugs and therapies that can effectively target cancer cells while minimizing damage to healthy cells.

Pharmaceutical oncology also encompasses clinical trials and regulatory processes that ensure the safety and efficacy of cancer drugs before they are approved for use by the general public. Additionally, it involves collaborating with healthcare professionals to develop treatment plans that are tailored to individual patients.

The goal of pharma oncology is to improve the survival rates and quality of life for cancer patients by providing them with access to safe and effective treatment options. Advances in pharma oncology have led to significant improvements in cancer care and have contributed to the development of targeted therapies and immunotherapies that are transforming the field of oncology.


    Related Conference of Pharma-Oncology

    January 25-26, 2024

    39th World Cardiology Conference

    London, UK
    February 08-09, 2024

    3rd International Conference on Cardiology

    Paris, France
    March 07-08, 2024

    38th World Congress on Heart Diseases

    Toronto, Canada
    March 11-12, 2024

    13th World Heart Congress

    Paris, France
    May 30-31, 2024

    6th Euro Cardiology Congress

    Vienna, Austria
    May 30-31, 2024

    39th World Congress on Heart Diseases

    Vienna, Austria
    June 20-21, 2024

    5th European Summit on Cardiology Research

    Dublin, Ireland
    July 16-17, 2024

    13th World Heart Congress

    Paris, France

    Pharma-Oncology Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in